A detailed history of Bcs Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Bcs Wealth Management holds 5,749 shares of ABT stock, worth $655,443. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,749
Previous 5,973 3.75%
Holding current value
$655,443
Previous $679,000 12.08%
% of portfolio
0.29%
Previous 0.22%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$100.73 - $112.44 $22,563 - $25,186
-224 Reduced 3.75%
5,749 $597,000
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $49,941 - $55,157
456 Added 8.27%
5,973 $679,000
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $527,039 - $632,358
5,517 New
5,517 $534,000
Q1 2023

Apr 10, 2023

SELL
$96.86 - $114.01 $261,618 - $307,941
-2,701 Reduced 47.65%
2,968 $301,000
Q3 2022

Oct 07, 2022

SELL
$96.76 - $112.03 $15,481 - $17,924
-160 Reduced 2.74%
5,669 $549,000
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $33,887 - $40,958
-332 Reduced 5.39%
5,829 $633,000
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $19,155 - $23,358
-168 Reduced 2.65%
6,161 $729,000
Q4 2021

Jan 18, 2022

BUY
$115.53 - $141.46 $15,249 - $18,672
132 Added 2.13%
6,329 $891,000
Q1 2021

Apr 28, 2021

SELL
$108.84 - $128.23 $1,306 - $1,538
-12 Reduced 0.19%
6,197 $743,000
Q4 2020

Jan 21, 2021

SELL
$105.0 - $114.42 $4,410 - $4,805
-42 Reduced 0.67%
6,209 $680,000
Q2 2020

Jul 21, 2020

BUY
$76.57 - $98.0 $1,225 - $1,568
16 Added 0.26%
6,251 $572,000
Q1 2020

Apr 10, 2020

BUY
$62.82 - $91.86 $391,682 - $572,747
6,235 New
6,235 $492,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bcs Wealth Management Portfolio

Follow Bcs Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bcs Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bcs Wealth Management with notifications on news.